Experimental vaccine fails to protect babies against TB

02/4/2013 | Medical News Today

The MVA85A vaccine has been developed to boost the immune responses of the Bacille Calmette-Guérin vaccine against tuberculosis, but a trial in South Africa found that the experimental vaccine was not as effective in babies as it has been shown to be in adults. The vaccine's efficacy rate of 17.3% was not statistically significant, researchers reported in The Lancet.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA